Paradoxical fluorescence after administration of 5-aminolevulinic acid for resection of a cerebral melanoma metastasis by Schucht, Philippe et al.
LETTER TO THE EDITOR
Paradoxical fluorescence after administration
of 5-aminolevulinic acid for resection of a cerebral melanoma
metastasis
Philippe Schucht & Jürgen Beck & Istvan Vajtai &
Andreas Raabe
Received: 16 February 2011 /Accepted: 2 March 2011 /Published online: 24 May 2011
# Springer-Verlag 2011
Sir,
Five-aminolevulinic acid (5-ALA) is increasingly used for
resection of high-grade glioma; however, little is known
of its fluorescent behavior in other cerebral tumors. In this
letter, we report our findings of a paradoxical fluorescent
pattern after administration of 5-ALA in a metastatic
melanoma.
A 69-year-old man was admitted for apraxia and disorien-
tation after a skiing accident. The patient’s previous medical
history included the excision of malignant melanomas 9 years
earlier, with no known metastatic spread. Magnetic resonance
imaging (MRI) showed a brightly enhancing, centrally
necrotic, solitary right frontal tumor mass, indicating a
glioblastoma or metastasis.
A solution of 1.5 g ALA was orally administered
4 h preoperatively. A craniotomy guided by neuronavigation
was performed, followed by durotomy. Using a surgical
microscope and light source at 5-ALA excitation wavelength
(OPMI Neuro/NC4 system-fluorescence kit, Carl Zeiss,
Oberkochen, Germany), neither bright nor vague fluorescence
was emitted by the tumor mass. The surrounding tissue,
however, exhibited solid red fluorescence up to a distance of
5 mm from the solid tumor core. The intraoperative navigation
system (Brainlab, Feldkirchen, Germany) confirmed that the
peritumoral “5-ALA-positive” fluorescent tissue was outside
the strongly enhancing tumor (MRI). Intraoperative cryosec-
tion analysis revealed no infiltrating tumor cells in the
“5-ALA-positive” tissue; however, the non-fluorescent
“5-ALA-negative” solid tumor mass showed metastatic
malignant melanoma. The postoperative MRI showed a gross
total resection of the tumor.
The gross surgical specimens were histologically exam-
ined. This included a nodule (3 × 2 × 2 cm) and six largely
intact mapping biopsy samples eachmeasuring approximately
0.3-0.4 cm in diameter. Samples were processed according to
standard histopathological techniques (fixation in 4% buffered
formalin; 3-μm thick sections; hematoxylin/eosin stain). Light
microscopy confirmed that the tumor nodule contained
amelanotic malignant melanoma (Fig. 1a). Conversely, all
mapping biopsies taken from the peritumoral fluorescent
tissue showed edematous cortical and subcortical brain
parenchyma with reactive gliosis that was devoid of tumor
infiltration (Fig. 1b-d).
To the best of our knowledge, this is the first reported
case of a resection procedure for cerebral melanoma
metastasis assisted by 5-ALA fluoroscopy. One study has
shown that the use of 5-ALA resulted in a significantly
improved rate of gross total resection that translated into
prolonged progression-free survival [2]. However, the
behavior of 5-ALA in cerebral lesions other than malignant
glioma, and its value for resection and impact on survival
remain undetermined. By analogy to malignant glioma, the
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potential benefits—such as a higher rate of complete
resections and prolonged local disease control—should be
considered for cerebral melanoma metastasis.
An absence of 5-ALA-induced fluorescence has been
described in some forms of metastatic deposits [4]. Utsuki
et al. [4] reported on a series of peritumoral tissue samples
from glioma and cerebral metastasis that had shown vague
fluorescence despite the lack of unambiguous infiltration by
tumor cells on histology. It has also been suggested that
some of the protoporphyrin IX produced in tumor cells may
spill outside the tumor boundaries and accumulate in the
surrounding tissue [3]. This is an unlikely explanation in
our case, since the tumor did not show protoporphyrin
accumulation. A vague fluorescence, despite the lack of
neoplastic cells, has been attributed to an inflammatory
reaction in surgeries for recurrent disease [1]. The pecu-
liarity of the present case is the observation of an
undescribed constellation of bright fluorescence in the
uninvolved perilesional tissue—as opposed to the lack of
signal within the tumor itself.
Although the distribution of fluorescence radically
departed from an expected pattern, it nevertheless proved
of great help in visualizing the tumor-brain interface. It is
likely that 5-ALA might evolve into a useful ancillary tool
for brain metastasis surgery, provided that consistent
fluorescence patterns will have emerged from current and
future research.
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Fig. 1 a Solid tumor mass
(upper two-thirds) composed of
plump epithelioid melanocytes
largely devoid of pigment gran-
ula (magnification ×150); rela-
tively sharp circumscription
toward peritumoral brain paren-
chyma (lower third) is observed.
b1-b6 (×5) Boxes in b2 and b3
indicate areas depicted at high
magnification (×200) in c and d,
respectively. c Detailed view of
peritumoral cortex shows reac-
tive astrogliosis with gemisto-
cytic morphology (arrows)
(×200). d Detailed view of
peritumoral white substance
reveals spongy to vacuolated
aspect due to edema. Reactive
astrocytes are highlighted by
arrows. All microphotographs
represent slides stained with
hematoxylin and eosin
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